Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 3
2010 1
2011 3
2012 1
2013 2
2014 3
2015 3
2016 2
2017 4
2018 3
2019 2
2020 3
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic evaluation of zoledronic acid.
De Luca A, Lamura L, Gallo M, Daniele G, D'Alessio A, Giordano P, Maiello MR, Pergameno M, Perrone F, Normanno N. De Luca A, et al. Among authors: gallo m. Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):911-8. doi: 10.1517/17425255.2011.585156. Epub 2011 May 13. Expert Opin Drug Metab Toxicol. 2011. PMID: 21563999 Review.
VEGF as a potential target in lung cancer.
Frezzetti D, Gallo M, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Normanno N, De Luca A. Frezzetti D, et al. Among authors: gallo m. Expert Opin Ther Targets. 2017 Oct;21(10):959-966. doi: 10.1080/14728222.2017.1371137. Epub 2017 Aug 30. Expert Opin Ther Targets. 2017. PMID: 28831824 Review.
FGFR-targeted therapeutics for the treatment of breast cancer.
De Luca A, Frezzetti D, Gallo M, Normanno N. De Luca A, et al. Among authors: gallo m. Expert Opin Investig Drugs. 2017 Mar;26(3):303-311. doi: 10.1080/13543784.2017.1287173. Epub 2017 Feb 6. Expert Opin Investig Drugs. 2017. PMID: 28121208 Review.
Pharmacokinetic evaluation of capecitabine in breast cancer.
Daniele G, Gallo M, Piccirillo MC, Giordano P, D'Alessio A, Del Giudice A, La Porta ML, Perrone F, Normanno N, De Luca A. Daniele G, et al. Among authors: gallo m. Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):225-35. doi: 10.1517/17425255.2013.759939. Epub 2013 Jan 10. Expert Opin Drug Metab Toxicol. 2013. PMID: 23301520 Review.
Vandetanib as a potential treatment for breast cancer.
De Luca A, D'Alessio A, Maiello MR, Gallo M, Bevilacqua S, Frezzetti D, Morabito A, Perrone F, Normanno N. De Luca A, et al. Among authors: gallo m. Expert Opin Investig Drugs. 2014 Sep;23(9):1295-303. doi: 10.1517/13543784.2014.942034. Epub 2014 Aug 4. Expert Opin Investig Drugs. 2014. PMID: 25089348 Review.
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer.
De Luca A, Maiello MR, D'Alessio A, Frezzetti D, Gallo M, Carotenuto M, Normanno N. De Luca A, et al. Among authors: gallo m. Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):891-900. doi: 10.1080/17425255.2018.1514720. Epub 2018 Sep 3. Expert Opin Drug Metab Toxicol. 2018. PMID: 30130984 Review.
The prognostic role of circulating tumor cells in lung cancer.
Normanno N, De Luca A, Gallo M, Chicchinelli N, Rossi A. Normanno N, et al. Among authors: gallo m. Expert Rev Anticancer Ther. 2016 Aug;16(8):859-67. doi: 10.1080/14737140.2016.1202767. Epub 2016 Jun 30. Expert Rev Anticancer Ther. 2016. PMID: 27337696 Review.
33 results